This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Tenet Healthcare (THC) Might Surprise This Earnings Season
by Zacks Equity Research
Tenet Healthcare (THC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Analysts Estimate HCA Healthcare (HCA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
HCA (HCA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tenet Healthcare (THC) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
Tenet (THC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Tenet Healthcare (THC) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Ensign Group (ENSG) Stock Up 6% Since Q2 Earnings Release
by Zacks Equity Research
Ensign Group's (ENSG) second-quarter results reflect revenue growth, and solid contributions from the Skilled Services and Standard Bearer segments. A hiked 2022 EPS guidance bodes well.
Tenet Healthcare (THC) Q2 Earnings Beat, Trims '22 EPS View
by Zacks Equity Research
Tenet Healthcare's (THC) second-quarter earnings benefit from strong Ambulatory Care and Conifer segments. However, a trimmed EPS view for 2022 might raise concerns for investors.
HCA Healthcare (HCA) Q2 Earnings Beat on Better Patient Volumes
by Zacks Equity Research
HCA Healthcare's (HCA) second-quarter results reflect improved revenues stemming from better same-facility emergency room visits. However, the results were partly offset by elevated salaries and benefits cost.
Tenet Healthcare (THC) Q2 Earnings Beat Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 108.33% and 4.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Factors Likely to Shape Tenet Healthcare's (THC) Q2 Earnings
by Zacks Equity Research
Tenet Healthcare's (THC) second-quarter results are likely to reflect the impact of lower contribution of the Hospital segment to overall revenues. The results might partly benefit from a downtrend in operating expenses.
Analysts Estimate HCA Healthcare (HCA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
HCA (HCA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Tenet Healthcare (THC) Q2 Earnings Expected to Decline
by Zacks Equity Research
Tenet (THC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Industry Outlook Highlights Acadia Healthcare, Pediatrix Medical, Tenet Healthcare and Discover Financial Services
by Zacks Equity Research
Acadia Healthcare, Pediatrix Medical, Tenet Healthcare and Discover Financial Services are part of Zacks Industry Outlook article.
2 Top Hospital Stocks to Buy Despite Industry Headwinds
by Kaibalya Pravo Dey
Rising supplies expense, wages and benefits, and other operating costs are lowering margins for the Zacks Medical-Hospital industry players. However, Acadia Healthcare and Pediatrix Medical are poised to win big with recovering patient volumes.
Implied Volatility Surging for Tenet Healthcare (THC) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Tenet Healthcare (THC) stock based on the movements in the options market lately.
Should iShares Morningstar SmallCap Value ETF (ISCV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for ISCV
Tenet Healthcare (THC) Unit Ties Up to Boost Urology Services
by Zacks Equity Research
Tenet Healthcare's (THC) unit, USPI, signs a joint venture partnership with UUG to acquire ownership interests in the latter's 22 ambulatory surgery centers and concurrently assuring to develop these centers.
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?
by Zacks Equity Research
Sector ETF report for PTH
Tenet Healthcare (THC) Unit Conifer Offers Services to Brookwood
by Zacks Equity Research
Tenet Healthcare's (THC) unit Conifer inks an agreement with Brookwood Baptist Health to deliver enhanced revenue cycle services to four of the remaining hospitals of the latter across Central Alabama.
Should iShares Russell 2000 ETF (IWM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWM
Should iShares Russell 2000 Value ETF (IWN) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWN
Why Is Tenet (THC) Down 26.4% Since Last Earnings Report?
by Zacks Equity Research
Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Encompass Health (EHC) Unveils Plan to Better Serve Texas
by Zacks Equity Research
Encompass Health (EHC) announces plans to construct a 60-bed inpatient rehabilitation hospital in Texas in a bid to more effectively cater to the health issues of the state.
Why Acadia Healthcare (ACHC) Dips 1.6% Despite Q1 Earnings Beat
by Zacks Equity Research
Acadia Healthcare (ACHC) aims to add around 300 beds to its existing facilities in 2022.
Mednax (MD) Down 20% Despite Q1 Earnings Beat on Patient Volumes
by Zacks Equity Research
Mednax (MD) continues to anticipate revenues of $2 billion and adjusted EBITDA of at least $270 million for 2022.
Should iShares Morningstar SmallCap Value ETF (ISCV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for ISCV